180-Day Exclusivity and Authorized Generics: Legal Considerations in the U.S. Drug Market
The 180-day exclusivity rule rewards generic drug makers for challenging patents, but brand-name companies can undercut them by launching authorized generics. Here's how the law works, why it's controversial, and what's changing.